Description
41,06,181 equity shares of Camlin Fine Sciences Limited issued at premium of Rs.246.69 to Non-Promoters on preferential basis pursuant to share swap, listed with effect from January 5, 2026.
Summary
Camlin Fine Sciences Limited (Scrip Code: 532834) has listed 41,06,181 equity shares of Re.1/- each on BSE, effective from January 5, 2026. These shares were issued at a premium of Rs.246.69 per share to Non-Promoters on a preferential basis pursuant to a share swap arrangement. The newly listed shares rank pari-passu with existing equity shares and are subject to lock-in until July 4, 2026.
Key Points
- 41,06,181 new equity shares of Re.1/- each listed on BSE
- Issue price: Rs.247.69 per share (face value Re.1 + premium Rs.246.69)
- Issued to Non-Promoters on preferential basis pursuant to share swap
- Allotment date: November 30, 2025
- Trading commencement date: January 5, 2026
- ISIN: INE052I01032
- Distinctive Numbers: 187980433 to 192086613
- Shares rank pari-passu with existing equity shares
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members are informed of the listing and permitted trading of these new securities effective from January 5, 2026.
Important Dates
- Allotment Date: November 30, 2025
- Trading Commencement Date: January 5, 2026
- Lock-in Expiry Date: July 4, 2026
Impact Assessment
This is a routine listing announcement for Camlin Fine Sciences Limited with minimal market impact. The preferential allotment of 41.06 lakh shares represents new equity capital raised through share swap. All shares are subject to standard lock-in until July 4, 2026, preventing immediate trading by allottees. The shares will be available for trading by other market participants from January 5, 2026, potentially affecting liquidity and price discovery for the scrip.
Impact Justification
Routine listing of preferential allotment shares for a single company with standard lock-in provisions, limited market-wide impact.